RA Kyle
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 16
- Glycosylation and Glycoproteins Research 4
- Hematology 19
- Multiple Myeloma Research and Treatments 19
- Co-authors
- PR Greipp (17 shared papers)MA Gertz (10 shared papers)W. Michael O’Fallon (5 shared papers)GW Dewald (2 shared papers)C. Mary Beard (2 shared papers)Kurland Lt (2 shared papers)Athena Linos (2 shared papers)R. P. Linke (2 shared papers)
- Partner nations
- United StatesIsraelPoland
In The Last Decade
RA Kyle
30 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 61
- Hematology 1.5k
- Genetics 612
- Nephrology 213
- Oncology 705
- Molecular Biology 1.7k
Countries citing papers authored by RA Kyle
This map shows the geographic impact of RA Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RA Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RA Kyle more than expected).
Fields of papers citing papers by RA Kyle
This network shows the impact of papers produced by RA Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RA Kyle. The network helps show where RA Kyle may publish in the future.
Co-authors
The 25 scholars most cited alongside RA Kyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 477 | |
| 2 | 1985 | 344 | |
| 3 | 1985 | 198 | |
| 4 | 1996 | 182 | |
| 5 | 1991 | 144 | |
| 6 | 1983 | 131 | |
| 7 | 1988 | 129 | |
| 8 | 1991 | 122 | |
| 9 | 1978 | 119 | |
| 10 | The spectrum of IgM mono-clonal gammopathy in 430 cases. | 1987 | 97 |
| 11 | 1996 | 93 | |
| 12 | 1996 | 93 | |
| 13 | 1996 | 87 | |
| 14 | 1996 | 85 | |
| 15 | 2000 | 83 | |
| 16 | 1989 | 42 | |
| 17 | 1999 | 41 | |
| 18 | 1986 | 23 | |
| 19 | 1985 | 21 | |
| 20 | 1992 | 15 |
About RA Kyle
RA Kyle is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Epidemiology, having authored 30 papers that have together received 2.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers), Cancer Treatment and Pharmacology (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Parathyroid Disorders and Treatments (4 papers), Glycosylation and Glycoproteins Research (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (612 citations), Nephrology (213 citations), Oncology (705 citations) and Molecular Biology (1.7k citations). RA Kyle has collaborated with scholars based in United States, Israel and Poland. Frequent co-authors include PR Greipp, MA Gertz, W. Michael O’Fallon, GW Dewald, C. Mary Beard, Kurland Lt, Athena Linos, R. P. Linke, Brian Van Ness and Daniel D. Billadeau. Their work appears in journals such as Blood, Bone Marrow Transplantation and Mayo Clinic Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.